Pharmaceuticals occupiers in Houston typically cluster in Galleria / Uptown, plan ~220 sqft per seat at high-end fit-out ($155–225/sqft), and pay around 35 USD/sqft ($35 USD) on Class A.
Pharmaceuticals occupiers in Houston typically cluster in Galleria / Uptown, plan ~220 sqft per seat at high-end fit-out">fit-out ($155–225/sqft), and pay around 35 USD/sqft ($35 USD) on Class A.
Pharmaceuticals occupiers in Houston typically anchor in Galleria / Uptown. Energy services, professional services, healthcare, financial services.
Class A rent in Houston runs 35 USD/sqft ($35 USD) on a 10-year lease with 18 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $155–225/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Houston typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Deepest energy talent pool in the Americas. Strong engineering, healthcare (Texas Medical Center), and aerospace bases. Tech and finance talent depth is limited compared to Dallas / Austin.
Headline corporate tax: 22.5%. Modified-gross structures with operating-expense pass-throughs. 10-15 year terms common for trophy energy tenants. Free rent of 16-24 months and TI of $80-$140/sqft typical. Heavy concession packages.
| city | Houston |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | Galleria / Uptown |
| preferredFitoutSpec | High-end |
| fitoutBand | $155–225/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 35 USD/sqft/yr |
| classARentUsd | $35/sqft/yr |
| vacancyPct | 26.7% |
| typicalLeaseYears | 10 |
| typicalRentFreeMonths | 18 |
| talentIndex | 78 |
| corporateTaxPct | 22.5% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.